Medios AG (ILM1) - Total Assets
Based on the latest financial reports, Medios AG (ILM1) holds total assets worth €903.04 Million EUR (≈ $1.06 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Medios AG (ILM1) shareholders funds for net asset value and shareholders' equity analysis.
Medios AG - Total Assets Trend (2009–2025)
This chart illustrates how Medios AG's total assets have evolved over time, based on quarterly financial data.
Medios AG - Asset Composition Analysis
Current Asset Composition (December 2025)
Medios AG's total assets of €903.04 Million consist of 38.1% current assets and 61.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €-1.00K | 9.1% |
| Accounts Receivable | €161.64 Million | 17.9% |
| Inventory | €93.32 Million | 10.3% |
| Property, Plant & Equipment | €73.05 Million | 8.1% |
| Intangible Assets | €124.05 Million | 13.7% |
| Goodwill | €360.59 Million | 39.9% |
Asset Composition Trend (2009–2025)
This chart illustrates how Medios AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ILM1 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medios AG's current assets represent 38.1% of total assets in 2025, a decrease from 74.0% in 2009.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2025, up from 1.3% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 39.9% of total assets.
Medios AG Competitors by Total Assets
Key competitors of Medios AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Medios AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.90 | 2.02 | 3.58 |
| Quick Ratio | 1.38 | 1.49 | 2.84 |
| Cash Ratio | 0.45 | 0.62 | 0.00 |
| Working Capital | €162.35 Million | €174.75 Million | €163.05 Million |
Medios AG - Advanced Valuation Insights
This section examines the relationship between Medios AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.34 |
| Asset Growth Rate (YoY) | -3.4% |
| Total Assets | €903.04 Million |
| Market Capitalization | $311.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medios AG's assets below their book value (0.34x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Medios AG's assets decreased by 3.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Medios AG (2009–2025)
The table below shows the annual total assets of Medios AG from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €903.04 Million ≈ $1.06 Billion |
-3.35% |
| 2024-12-31 | €934.36 Million ≈ $1.09 Billion |
+57.10% |
| 2023-12-31 | €594.75 Million ≈ $695.33 Million |
+3.26% |
| 2022-12-31 | €575.96 Million ≈ $673.36 Million |
+9.89% |
| 2021-12-31 | €524.14 Million ≈ $612.78 Million |
+169.43% |
| 2020-12-31 | €194.54 Million ≈ $227.43 Million |
+66.89% |
| 2019-12-31 | €116.57 Million ≈ $136.28 Million |
+18.44% |
| 2018-12-31 | €98.42 Million ≈ $115.06 Million |
+59.49% |
| 2017-12-31 | €61.71 Million ≈ $72.14 Million |
+28.93% |
| 2016-12-31 | €47.86 Million ≈ $55.95 Million |
+9299.04% |
| 2015-12-31 | €509.21K ≈ $595.32K |
+467.16% |
| 2014-12-31 | €89.78K ≈ $104.97K |
-61.69% |
| 2013-12-31 | €234.35K ≈ $273.98K |
-46.87% |
| 2012-12-31 | €441.11K ≈ $515.70K |
-32.91% |
| 2011-12-31 | €657.48K ≈ $768.66K |
-23.50% |
| 2010-12-31 | €859.39K ≈ $1.00 Million |
-80.74% |
| 2009-12-31 | €4.46 Million ≈ $5.22 Million |
-- |
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, a… Read more